Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;40(3):849-855.
doi: 10.1007/s10067-020-05328-5. Epub 2020 Aug 10.

Kawasaki disease in siblings in close temporal proximity to each other-what are the implications?

Aaqib Zaffar Banday  1 , Deepanjan Bhattacharya  1 , Vignesh Pandiarajan  1 , Surjit Singh  2
Affiliations
Review

Kawasaki disease in siblings in close temporal proximity to each other-what are the implications?

Aaqib Zaffar Banday et al. Clin Rheumatol. 2021 Mar.

Abstract

Kawasaki disease (KD) is the commonest medium vessel vasculitis in children. The etiology of KD remains an enigma despite extensive research. Infections are considered to be one of the triggers for KD, especially in genetically susceptible hosts. KD occurring within a short time interval among siblings is an important clinical observation supporting this hypothesis. In addition, siblings of children with KD are at a higher risk of developing the disease as compared with other children. Screening for KD in febrile siblings, therefore, seems prudent. This would help initiate timely therapy and prevent complications. We briefly review 16 English language reports of KD in siblings diagnosed within 1 month of each other to highlight its etiological and therapeutic implications. Key Points • KD should be suspected in febrile children who have a sibling recently diagnosed with KD. • Etiological studies should also focus on siblings who develop KD in close temporal proximity.

Keywords: Etiology; Infection; Kawasaki disease; Screening; Siblings.

PubMed Disclaimer

References

    1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi: 10.1161/CIR.0000000000000484. - DOI - PubMed
    1. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D'Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771–1778. doi: 10.1016/S0140-6736(20)31103-X. - DOI - PMC - PubMed
    1. Genzlinger N (2020) Dr. Tomisaku Kawasaki, who pinpointed a mysterious disease, dies at 95. The New York Times. https://nyti.ms/2YMDEX8. Accessed 7 July 2020
    1. Nakamura A, Ikeda K, Hamaoka K. Aetiological significance of infectious stimuli in Kawasaki disease. Front Pediatr. 2019;7:244. doi: 10.3389/fped.2019.00244. - DOI - PMC - PubMed
    1. Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee JW. Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr. 2013;172(3):343–349. doi: 10.1007/s00431-012-1891-5. - DOI - PubMed